Biogen Idec, Inc. (BIIB) Reports Solid Q2 Results
Biogen Idec, Inc. (NASDAQ: BIIB) reported Q2 EPS of $1.82 ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)